cells, leading to the destruction of bone and cartilage. At present, the clinical treatment aims to control inflammation as much as possible and reduce bone erosion by inhibiting synovial cells proliferation, angiogenesis, and pannus formation. 4 In the pathogenesis of RA, extracellular signal-regulated kinase (ERK) is activated by some cytokines. The activation of ERK pathway is associated with interleukin 1β (IL-1β), tumor necrosis factor α (TNF-α), vascular endothelial growth factor (VEGF), and angiopoietin-1 (Ang-1) to participate in synovial proliferation and angiogenesis in RA, then eventually leading to bone erosion. 5 In this experiment, the possible mechanism of inhibition of ERK pathway on synovial hyperplasia and angiogenesis in RA was preliminarily investigated from the perspectives of activation of cytokines and ERK pathway.
Material and methods

Animal
Thirty six female Sprague-Dawley rats, 7 weeks old, weighing (210 ± 25) g, were purchased from Beijing Vital-Lihua Experimental Animal Technology Co., Ltd.
Drugs
ERK pathway inhibitor U0126 was purchased from Bio-Sciences (Shanghai) Co., Ltd.
Reagents and equipment
Immune-derived bovine type II collagen (Chondrex); Complete Freund's adjuvant (Chondrex); Ang-1 enzyme-linked immunosorbent assay (ELISA) kits, TNF-α ELISA kits, VEGF ELISA kits, and IL-1β ELISA kits were obtained from Cusabio Company; Ultra-pure RNA extraction kit was purchased from Hefei Bomei biotechnology company. 
Grouping and modeling of animals
The rats were randomly divided into normal group, model group, and intervention group, with 12 rats in each group. In condition of sterile environment in the ultra-clean table, the cow type II collagen mixed with complete Freund's adjuvant in ice by 1:1. Then, utilizing a homogenizer fully emulsified it to the water-in-oil phase, and it does not spread when dripping into the water. The final concentration of bovine type II collagen in the emulsion is 1 mg/mL. Except the normal group rats, the remaining rats were immunized for the first time by being subcutaneously injected with 0.15-mL collagen emulsion after the rats adapted to the environment for a week. Then the immunization of rats was intensified once on the 7th day after the first immunization, and the method was the same as used in the first immunization.
Methods of administration
From the 14th day after the first immunization, rats in the intervention group were orally administrated with 400 μg/kg ERK pathway inhibitor U0126 once a day for 28 days. Meanwhile, the model group rats and the normal groups were not given special drug treatment.
Determination of cytokines in serum and synovial tissue
After 28 days of administration, rats in each group were anesthetized with 10% chloral hydrate, then the blood was taken from abdominal aorta to collect serum, and synovial tissue of knee joint was separated. The levels of IL-1β, TNF-α, VEGF, and Ang-1 in serum and synovial tissue were determined by ELISA, and the procedure was performed strictly according to the instructions in the kit.
Determination of cytokine mRNA expression in synovial tissue
We extracted the total RNA from synovial tissue according to manual operation, and then carried on reverse transcription and PCR amplification. The reaction conditions were denaturation at 95°C for 30 s, annealing at 60°C for 1 min, then extension at 72°C for 1 min, totally for 30 cycles, and the last cycle was extended at 72°C for 7 min. And the amplified product was electrophoresed in 1.5% agarose gel, analyzed by LEICAQ-500IW image analysis system, and the relative expression of mRNA was calculated by determining the integral optical density ratio of the target gene and the internal reference.
Protein expression of ERK pathway in synovial tissue
Western Blot method was used to detect the protein expression of ERK pathway in synovial tissue. First, take the synovial tissue, and then use precooled phosphate buffered saline (PBS) washing it twice. After 1 mL cell lysate was lysed on ice for 30 min, the tissue was centrifuged at 12,000 r/min for 30 min at 4°C and received the total tissue protein by drawing the supernatant. The protein expression of total ERK1/2 and its phosphorylated state (p-ERK1/2) were determined by BCA method. And the quantitative total tissue protein was mixed with protein electrophoresis loading buffer, then boiling it in the water for 5 mins. After the separated gel and concentrated gel were prepared, the SDS-PAGE electrophoresis was carried out. The membrane was sealed with 3% BSA after transformed in 200 mA for 2 h, then added the primary antibody followed by overnight incubation at 4°C. After that, the membranes were washed and incubated with secondary antibody (rabbit antigoat IgG) for 1 h at room temperature. At last, wash it and scan the image for analysis.
Methods of measuring the volume of hind limbs of rats
A proper amount of water was installed in a small test tube with a scale of 10 mL. The rats were fixed and the hind limbs (including the whole foot palmar) were fixed. The anatomic mark at the medial malleolus at the lower end of the tibia was used to observe and record the rising value of the water surface.
HE staining and immunohistochemistry
Joint tissues of rats were immersed in 4% paraformaldehyde for 4 h, and transferred to 70% ethanol. Individual lobes of joint tissues biopsy material were placed in processing cassettes, dehydrated through a serial alcohol gradient, and embedded in paraffin wax blocks. Before immunostaining, 5-µm-thick lung tissue sections were dewaxed in xylene, rehydrated through decreasing concentrations of ethanol, and washed in PBS, and then stained with hematoxylin and eosin (H&E). After staining, sections were dehydrated through increasing concentrations of ethanol and xylene.
Statistical methods
SPSS 21.0 statistical software was used for the measurement. The quantitative data were expressed as mean ± standard deviation, and the analysis of variance (ANOVA) was used to compare the mean of multiple groups. T-test was used to compare the quantitative data between two groups. A value of P < 0.05 was considered statistically significant.
Results
Comparison of serum cytokines expression levels in various groups of rats
The levels of IL-1β, TNF-α, and Ang-1 in the serum of model group were significantly increased (P < 0.05) compared to the normal group. In contrast with the model group, the levels of IL-1β, TNF-α, and Ang-1 in the intervention group were all significantly decreased (P < 0.05), while the level of VEGF in serum was not detected in all groups, as shown in Table 1 . IL-1β, interleukin 1β; TNF-α, tumor necrosis factor α; Ang-1, angiopoietin-1.
Comparison of cytokine levels in synovial tissue of rats in each group
The expression of IL-1β, TNF-α, VEGF, and Ang-1 in the synovial tissue of the model group was distinctly higher than those in the normal group (P < 0.05). Simultaneously, the levels of these cytokines in the intervention group were obviously decreased compared to the model group (P < 0.05) as shown in Table 2 .
Comparison of cytokines mRNA expression in synovial tissue of rats in each group
The mRNA expressions of IL-1β, TNF-α, VEGF, and Ang-1 in the synovial tissue of model group were significantly higher than those in normal group (P < 0.05), while the levels of these cytokine mRNA expression in synovial tissue of intervention group were significantly decreased (P < 0.05), as shown in Table 3 .
Comparison of arthritis index and arthritis volume in synovial tissue of rats in different groups
The arthritis index and arthritis volume in the synovial tissue of model group was significantly higher than those in normal group (P < 0.05), while the specific indicators in synovial tissue were significantly decreased in intervention group (P < 0.05), as shown in Table 4 .
Comparison of p-ERK1/2, p-JNK, and p-P38 pathway protein expression in synovial tissue of rats in different groups
The expression of p-ERK1/2, p-JNK, and p-P38 in model group was significantly higher than that in normal group (P < 0.05). The expression of p-ERK1/2 in intervention group rats was evidently decreased than model groups (P < 0.05). However, there is no difference of p-JNK and p-P38 protein expression in intervention group. Finally, there was no statistical significance in the expression of total ERK1/2 in each group (P > 0.05). The results were demonstrated in Figure 1 .
Comparison of HE staining and immunohistochemistry in synovial tissue of rats in different groups
Compared with the normal group, the synovial membrane of the model group was obviously hypertrophic, up to six to eight layers, arranged in disorder, a large number of inflammatory cells were infiltrated in the synovial membrane, and the articular cartilage and bone structure were disorganized. In the joint of the intervention group, there was still a certain degree of ambiguity in the joint space. The synovial cells could be seen in three to four layers under the microscope. The arrangement of the synovial cells was still disturbed and inflammatory cells infiltrated, but all of them were obviously better than the model group as shown in Figure 2 .
Discussion
RA is a common autoimmune disease with high morbidity, which is one of the major diseases that cause loss of workforce and disability, and seriously affects the quality of life of patients. The incidence of RA is related to heredity, autoimmunity, and environmental factors. 6 The main pathological features of RA are a variety of inflammatory cell proliferation, infiltration; joint synovial hyperemia, edema; loose tissue, and increased capillary permeability under the condition of inflammatory stimulation. Then the serous fluid and cellulose exuded to the joint cavity, subsequently generating tumor necrosis factor and VEGF together with other cytokines synthetized by joint synovial cells to promote synovial fibroblast proliferation and microvascular angiogenesis, followed by the formation of highly destructive pannus. As a key pathological process of RA, pannus grows like tumor invasive growth, invading the underlying cartilage and bone, leading to destruction of articular cartilage and bone, thus resulting in joint remodeling. 7 Previous studies 8 showed that cytokines involved in the entire pathological process of RA, moreover, both the IL-1β and TNF-α are the most important pathogenic factors. After the synovial IL-1β and TNF-α combined with their own receptor, the synoviocyte signaling is induced to cause an unlimited proliferation of RA synovial cells. Synovial tissue fibroblasts and neutrophils and other inflammatory cells can secrete a large number of VEGF, as a key factor of synovial pannus and maintain its biological state which can induce vascular proliferation and promote the inflammatory synovial tissue to generate new blood vessels and vascular material extravasation attributing to the formation of synovial tissue inflammation and pannus. Angiogenesis is associated with angiogenesis in the synovial pannus of RA. In addition, Ang-1 is closely related to angiogenesis in RA and plays an important role in stabilizing blood vessels and promoting vascular maturation. 9 Angiogenesis can be stimulated by the synergistic effect of VEGF and Ang-1, at the same time, ERK pathway is involved in the transduction of pathological signals of RA associated synovial tissue, promoting the proliferation of T cells and the secretion of various cytokines, causing the aggregation and activation of monocytes and macrophages, further secreting TNF-1β and other inflammatory cytokines. 10 The mechanism of action of VEGF and Ang-1 on RA synovial neovascularization and pannus is related to increasing ERK activity or activating ERK. 11 U0126 is a highly selective MEK inhibitor that specifically inhibits MEK/ERK pathway activity. U0126 can block the damage of neurons induced by tryptophan or camptothecin and can also reduce the neuronal cell death caused by glutamine deficiency together with the damage of hippocampal nerve caused by brain trauma. 12 The experimental results showed that the rats intervened with U0126 could significantly reduce the infiltration of inflammatory cells, and delay destructive effect of bone and cartilage. In the detection of cytokines, external application of compound Tripterygium wilfordii can significantly reduce the level of IL-1β, TNF-α, and Ang-1 in the serum of the arthritis rats and decrease the contents of IL-1β, TNF-α, VEGF, Ang-1 as well as the expression of p-ERK1/2 in synovial tissue of the intervention group were obviously lower than those in the model group, demonstrating that inhibition of the ERK pathway can reduce the inflammatory cytokines in the serum and synovial tissue of the arthritic rats, and synovial tissue ERK pathway activation, thereby inhibiting the proliferation of synovial tissue, reducing synovial angiogenesis and formation of pannus. In summary, inhibition of ERK pathway may reduce the inflammatory cytokines of arthritis synovial tissue and decrease the ERK pathway activation so that it can suppress the proliferation of synovial tissue and lessen the formation of synovial angiogenesis and pannus.
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